Literature DB >> 1382452

Synthetic peptides as vaccines.

R Arnon1, R J Horwitz.   

Abstract

The use of synthetic peptides as an alternative approach to vaccination is currently being pursued. This is particularly true for viral and parasitic diseases in which no vaccines are yet available, most notably the acquired immune deficiency syndrome.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1382452     DOI： 10.1016/s0952-7915(06)80037-3

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  15 in total

1.  F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes.

Authors:  C Liu; J Goldstein; R F Graziano; J He; J K O'Shea; Y Deo; P M Guyre
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.

Authors:  James S Testa; Vivekananda Shetty; Gomathinayagam Sinnathamby; Zacharie Nickens; Julie Hafner; Shivali Kamal; Xianchao Zhang; Marti Jett; Ramila Philip
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

3.  Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720).

Authors:  A A Scalzo; S L Elliott; J Cox; J Gardner; D J Moss; A Suhrbier
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

4.  A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.

Authors:  Xiaofang Huang; Aykan Karabudak; Joseph D Comber; Mohan Philip; Tulin Morcol; Ramila Philip
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

5.  Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation.

Authors:  A M Luo; K M Garza; D Hunt; K S Tung
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

6.  Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopes.

Authors:  E Lett; S Gangloff; M Zimmermann; D Wachsmann; J P Klein
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

Review 7.  Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

Authors:  E AlonsoDeVelasco; A F Verheul; J Verhoef; H Snippe
Journal:  Microbiol Rev       Date:  1995-12

8.  Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.

Authors:  G Baier; G Baier-Bitterlich; D J Looney; A Altman
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.

Authors:  O E Obeid; C D Partidos; C R Howard; M W Steward
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

10.  Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine.

Authors:  C Brander; W J Pichler; G Corradin
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.